Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial
暂无分享,去创建一个
A. Dubey | T. Wartel | A. Bouckenooghe | J. Chhatwal | S. Ganguly | S. Agarkhedkar | J. Menezes | Arun Narayan
[1] Rana F. Hamdy. Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America. , 2015, Journal of the Pediatric Infectious Diseases Society.
[2] J. Torresi,et al. Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: a randomised study. , 2015, Vaccine.
[3] Alan L Rothman,et al. Sequential dengue virus infections detected in active and passive surveillance programs in Thailand, 1994–2010 , 2015, BMC Public Health.
[4] G. Carrasquilla,et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. , 2015, The New England journal of medicine.
[5] M. R. Capeding,et al. Immunogenicity and safety of a tetravalent dengue vaccine during a five-year follow-up period , 2015 .
[6] Y. Halasa,et al. Economic and Disease Burden of Dengue Illness in India , 2014, The American journal of tropical medicine and hygiene.
[7] P. Pitisuttithum,et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial , 2014, The Lancet.
[8] Derek A T Cummings,et al. A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand. , 2014, The Journal of infectious diseases.
[9] R. Dietze,et al. Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in Brazil , 2013, The American journal of tropical medicine and hygiene.
[10] Y. Hutagalung,et al. Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2-11 years in Malaysia: a randomized, placebo-controlled, Phase III study. , 2013, Vaccine.
[11] S. Halstead. Identifying protective dengue vaccines: guide to mastering an empirical process. , 2013, Vaccine.
[12] John S. Brownstein,et al. The global distribution and burden of dengue , 2013, Nature.
[13] M. Kakkar,et al. Dengue fever is massively under-reported in India, hampering our response , 2012, BMJ : British Medical Journal.
[14] J. Lang,et al. Safety and Immunogenicity of Recombinant, Live Attenuated Tetravalent Dengue Vaccine (CYD- TDV) in Healthy Vietnamese Adults and Children , 2012 .
[15] Saravudh Suvannadabba,et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial , 2012, The Lancet.
[16] L. Shek,et al. Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 years , 2012, Human Vaccines & Immunotherapeutics.
[17] Rohit Arora,et al. Fifty years of dengue in India. , 2012, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[18] L. Shek,et al. Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in Singapore. , 2012, Human vaccines & immunotherapeutics.
[19] J. Lang,et al. Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humans. , 2011, The American journal of tropical medicine and hygiene.
[20] J. Lang,et al. Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines. , 2011, Vaccine.
[21] P. Garg,et al. Economic burden of dengue infections in India. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[22] M. A. Rai,et al. Dengue: Indian subcontinent in the line of fire. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[23] Susana Vázquez,et al. Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. , 2002, Revista panamericana de salud publica = Pan American journal of public health.